{"id":19695,"date":"2020-06-03T11:22:41","date_gmt":"2020-06-03T09:22:41","guid":{"rendered":"https:\/\/www.satt.fr\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/"},"modified":"2020-06-03T11:22:41","modified_gmt":"2020-06-03T09:22:41","slug":"levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus","status":"publish","type":"post","link":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/","title":{"rendered":"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus"},"content":{"rendered":"<p><strong>Dynacure, a clinical stage drug development company supported by SATT Conectus at the beginning of the story, announced the close of a \u20ac50 million Series C financing led by Perceptive Advisors.<br \/>\n<\/strong><img loading=\"lazy\" decoding=\"async\" class=\"alignright size-medium wp-image-19633\" src=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-300x166.jpg\" alt=\"Home page site web Dynacure\" width=\"300\" height=\"166\" srcset=\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-300x166.jpg 300w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-150x83.jpg 150w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-768x424.jpg 768w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-1024x566.jpg 1024w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-500x276.jpg 500w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-600x331.jpg 600w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure-181x100.jpg 181w, https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Capture-Dynacure.jpg 1611w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><br \/>\nNew investors participating in this financing include Bpifrance Large Venture and funds managed by Tekla Capital Management LLC. Dynacure\u2019s existing investors Andera Partners, Bpifrance through its FABS and Fonds Bioth\u00e9rapies Innovantes et Maladies Rares funds, Kurma Partners and Pontifax also meaningfully participated. In connection with the financing, Henry Skinner, Ph.D., Senior Vice President of Tekla Capital Management, will join the Dynacure board of directors.<\/p>\n<ul>\n<li><em>\u201cWe are excited to partner with Dynacure as they pioneer the use of antisense therapy for the treatment of Myotubular and Centronuclear Myopathies,\u201d said Ellen Hukkelhoven, Managing Director of Perceptive Advisors. \u201cPerceptive has long been committed to supporting novel approaches in rare diseases and we look forward to working with the dedicated team at Dynacure to bring DYN101 and other medicines to patients faster.\u201d<\/em><\/li>\n<\/ul>\n<p>DYN101 is an investigational antisense medicine designed to modulate the expression of dynamin 2 (DNM2) for the treatment of Myotubular and Centronuclear Myopathies (CNM). Proceeds from the financing will be used to advance Dynacure\u2019s lead program, DYN101, through an ongoing Phase 1\/2 clinical trial in adults, expand the DYN101 clinical program to include treatment of pediatric patients and to continue to grow the company and its pipeline.<\/p>\n<ul>\n<li><em>\u201cSince the company\u2019s inception in 2016, Dynacure has made significant progress in a very short time, resulting in the first CNM patient dosed with their antisense medicine, DYN101, in March 2020,\u201d said Laurent Higueret, Investment Director at Bpifrance Large Venture. \u201cWe view this financing as our commitment to supporting Dynacure as they advance DYN101 and become one of the industry\u2019s future rare disease leaders.\u201d\n<p><\/em><\/li>\n<li><em>\u201cWith the support of our outstanding group of investors, this financing positions us well to advance DYN101 through Phase 1\/2 clinical evaluation in both adult and pediatric patients and expand our pipeline into other rare muscle disorders to strengthen Dynacure\u2019s growth,\u201d said Stephane van Rooijen (M.D. MBA), Chief Executive Officer of Dynacure<\/em>.<\/li>\n<\/ul>\n<p>CNMs are serious, rare, life-threatening disorders that affect skeletal muscles from birth. Centronuclear Myopathies affect between 4,000 and 5,000 patients in the EU, US, Japan and Australia1. DYN101 is being developed in collaboration with Ionis Pharmaceuticals, the leader in RNA-targeted drug discovery. Preclinical efficacy observed in multiple mouse models of the disease gives confidence in the ability to demonstrate potential disease-modifying results in humans.<\/p>\n<p>\n<\/p>\n<p><a href=\"https:\/\/www.dynacure.com\/news\/dynacure-announces-e50m-55m-series-c-financing\/\"><strong>Read the whole press release<\/strong><\/a><br \/>\n<a href=\"https:\/\/www.dynacure.com\/company\/\"><strong>About Dynacure<\/strong><\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Dynacure, a clinical stage drug development company supported by SATT Conectus at the beginning of the story, announced the close of a \u20ac50 million Series C financing led by Perceptive Advisors. New investors participating in this financing include Bpifrance Large Venture and funds managed by Tekla Capital Management LLC. Dynacure\u2019s existing investors Andera Partners, Bpifrance [&hellip;]<\/p>\n","protected":false},"author":7,"featured_media":19644,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[567,568,604],"tags":[],"class_list":["post-19695","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news-en","category-successstories-en","category-startup-en"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.2 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"France MANDRY\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\"},\"author\":{\"name\":\"France MANDRY\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"headline\":\"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus\",\"datePublished\":\"2020-06-03T09:22:41+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\"},\"wordCount\":427,\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg\",\"articleSection\":[\"News\",\"Success Stories\",\"Start-up\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\",\"url\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\",\"name\":\"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT\",\"isPartOf\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg\",\"datePublished\":\"2020-06-03T09:22:41+00:00\",\"author\":{\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\"},\"breadcrumb\":{\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage\",\"url\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg\",\"contentUrl\":\"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg\",\"width\":3200,\"height\":1785},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.satt.fr\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.satt.fr\/en\/#website\",\"url\":\"https:\/\/www.satt.fr\/en\/\",\"name\":\"R\u00e9seau SATT\",\"description\":\"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.satt.fr\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e\",\"name\":\"France MANDRY\",\"url\":\"https:\/\/www.satt.fr\/en\/author\/france\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/","twitter_misc":{"Written by":"France MANDRY","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#article","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/"},"author":{"name":"France MANDRY","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"headline":"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus","datePublished":"2020-06-03T09:22:41+00:00","mainEntityOfPage":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/"},"wordCount":427,"image":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg","articleSection":["News","Success Stories","Start-up"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/","url":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/","name":"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus - R\u00e9seau SATT","isPartOf":{"@id":"https:\/\/www.satt.fr\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage"},"image":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage"},"thumbnailUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg","datePublished":"2020-06-03T09:22:41+00:00","author":{"@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e"},"breadcrumb":{"@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#primaryimage","url":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg","contentUrl":"https:\/\/www.satt.fr\/wp-content\/uploads\/2020\/06\/Dynacure.jpg","width":3200,"height":1785},{"@type":"BreadcrumbList","@id":"https:\/\/www.satt.fr\/en\/levee-de-fonds-record-pour-dynacure-startup-propulsee-par-la-satt-conectus\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.satt.fr\/en\/"},{"@type":"ListItem","position":2,"name":"Lev\u00e9e de fonds record pour Dynacure, startup propuls\u00e9e par la SATT Conectus"}]},{"@type":"WebSite","@id":"https:\/\/www.satt.fr\/en\/#website","url":"https:\/\/www.satt.fr\/en\/","name":"R\u00e9seau SATT","description":"Les Soci\u00e9t\u00e9s d&#039;Acc\u00e9l\u00e9ration du Transfert de Technologies","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.satt.fr\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.satt.fr\/en\/#\/schema\/person\/3c07a164c17f01f656480221ba81ab4e","name":"France MANDRY","url":"https:\/\/www.satt.fr\/en\/author\/france\/"}]}},"_links":{"self":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/19695","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/users\/7"}],"replies":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/comments?post=19695"}],"version-history":[{"count":0,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/posts\/19695\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media\/19644"}],"wp:attachment":[{"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/media?parent=19695"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/categories?post=19695"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.satt.fr\/en\/wp-json\/wp\/v2\/tags?post=19695"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}